These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21931028)

  • 1. No place like home? Outpatient management of patients with febrile neutropenia and low risk.
    Freifeld AG; Sepkowitz KA
    J Clin Oncol; 2011 Oct; 29(30):3952-4. PubMed ID: 21931028
    [No Abstract]   [Full Text] [Related]  

  • 2. Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial.
    Hendricks AM; Loggers ET; Talcott JA
    J Clin Oncol; 2011 Oct; 29(30):3984-9. PubMed ID: 21931037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial.
    Talcott JA; Yeap BY; Clark JA; Siegel RD; Loggers ET; Lu C; Godley PA
    J Clin Oncol; 2011 Oct; 29(30):3977-83. PubMed ID: 21931024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
    Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
    Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients.
    Teuffel O; Amir E; Alibhai S; Beyene J; Sung L
    Br J Cancer; 2011 Apr; 104(9):1377-83. PubMed ID: 21468048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
    Sung L; Feldman BM; Schwamborn G; Paczesny D; Cochrane A; Greenberg ML; Maloney AM; Hendershot EI; Naqvi A; Barrera M; Llewellyn-Thomas HA
    J Clin Oncol; 2004 Oct; 22(19):3922-9. PubMed ID: 15459214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are we finally ready for outpatient management of febrile neutropenia?
    Saini S; Rosoff PM
    Pediatr Blood Cancer; 2007 Nov; 49(6):765-6. PubMed ID: 17514730
    [No Abstract]   [Full Text] [Related]  

  • 8. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
    Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.
    Rubenstein EB; Rolston KV; Kim YJ
    N Engl J Med; 2000 Jan; 342(1):56; author reply 56-8. PubMed ID: 10627211
    [No Abstract]   [Full Text] [Related]  

  • 10. Current attitudes for therapy of febrile neutropenia with consideration to cost-effectiveness.
    Klastersky J
    Curr Opin Oncol; 1998 Jul; 10(4):284-90. PubMed ID: 9702394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.
    Sezer O
    N Engl J Med; 2000 Jan; 342(1):56; author reply 56-8. PubMed ID: 10627212
    [No Abstract]   [Full Text] [Related]  

  • 12. The evolution towards ambulatory and day-case management of febrile neutropenia.
    Chisholm JC; Dommett R
    Br J Haematol; 2006 Oct; 135(1):3-16. PubMed ID: 16925575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.
    Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Cumsille MA; O'Ryan ML; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    J Clin Oncol; 2004 Sep; 22(18):3784-9. PubMed ID: 15365075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule.
    Talcott JA; Whalen A; Clark J; Rieker PP; Finberg R
    J Clin Oncol; 1994 Jan; 12(1):107-14. PubMed ID: 8270967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer.
    Teuffel O; Amir E; Alibhai SM; Beyene J; Sung L
    Pediatrics; 2011 Feb; 127(2):e279-86. PubMed ID: 21220399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
    Sebban C; Dussart S; Fuhrmann C; Ghesquieres H; Rodrigues I; Geoffrois L; Devaux Y; Lancry L; Chvetzoff G; Bachelot T; Chelghoum M; Biron P
    Support Care Cancer; 2008 Sep; 16(9):1017-23. PubMed ID: 18197434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia.
    Sung L; Alibhai SM; Ethier MC; Teuffel O; Cheng S; Fisman D; Regier DA
    J Clin Epidemiol; 2012 Jun; 65(6):627-34. PubMed ID: 22424607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.
    Taplitz RA; Kennedy EB; Bow EJ; Crews J; Gleason C; Hawley DK; Langston AA; Nastoupil LJ; Rajotte M; Rolston K; Strasfeld L; Flowers CR
    J Clin Oncol; 2018 May; 36(14):1443-1453. PubMed ID: 29461916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost analysis of febrile neutropenia management in Australia: ambulatory v. in-hospital treatment.
    Lingaratnam S; Worth LJ; Slavin MA; Bennett CA; Kirsa SW; Seymour JF; Dalton A; Koczwara B; Prince HM; O'Reilly M; Mileshkin L; Szer J; Thursky KA
    Aust Health Rev; 2011 Nov; 35(4):491-500. PubMed ID: 22126955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
    Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
    Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.